Tirzepatide (Mounjaro) is an innovative weight-loss medication that has quickly become one of the most in-demand treatments for obesity and type 2 diabetes. By targeting both GLP-1 and GIP receptors, Mounjaro effectively reduces appetite, improves blood sugar regulation, and increases the feeling of fullness, making sustainable weight management more achievable.
At FagerCare, we provide Tirzepatide (Mounjaro) as part of our medical weight-loss program, offering professional guidance and support to help you reach your health and weight goals safely and effectively.
Tirzepatide, sold under the brand name Mounjaro, is a new generation weight-loss and diabetes medication. It works by activating two important hormone receptors, GLP-1 and GIP, which are normally released from the gut after eating. These hormones send signals to the brain that regulate appetite and blood sugar.
By enhancing these natural processes, Mounjaro helps you feel fuller for longer, reduces hunger, and improves blood sugar control. Clinical studies have shown that Tirzepatide can lead to significant weight reduction. The most common side effects include nausea and mild gastrointestinal discomfort, especially in the beginning of treatment.
BMI is a practical tool to estimate whether your weight is within a healthy range in relation to your height. By using a simple formula (your weight divided by your height squared in meters), BMI can indicate if you are underweight, of normal weight, overweight or obese.
Our medications are recommended for individuals with obesity (a BMI of 30 or higher) or overweight (BMI between 27 and 30) where complications or risk factors exist, such as high blood pressure, elevated cholesterol, high blood sugar, atherosclerosis or sleep apnea.
We have compiled the most frequently asked questions about Mounjaro to make it easy for you to find the answers you need. If you have additional questions or concerns not covered here, don’t hesitate to contact us – we are here to assist you and provide answers to all your queries.
Tirzepatide mimics the natural hormones GLP-1 and GIP, which regulate appetite and blood sugar. This helps you eat less, feel fuller, and lose weight more effectively.
Mounjaro is administered as a once-weekly injection under the skin. It is simple to use and fits easily into most lifestyles.
Clinical studies show that Mounjaro can help patients achieve significant and sustained weight loss, especially when combined with healthy lifestyle changes.
The most common side effects are mild and temporary, such as nausea or digestive discomfort, usually occurring at the start of treatment.
Copyright © 2024 FagerCare
Produced by Searchminds
